Seeking Alpha

demand

demand
Send Message
View as an RSS Feed
View demand's Comments BY TICKER:
Latest  |  Highest rated
  • A.P. Pharma: Refiling Of NDA For APF530 Could Cause Price Strength [View article]
    No milestone or royalty obligations owed to any third parties
    Oct 7 01:31 AM | Likes Like |Link to Comment
  • A.P. Pharma: Refiling Of NDA For APF530 Could Cause Price Strength [View article]
    No long-acting injectable alternative to Aloxi is available to prevent
    delayed-onset CINV
    Oct 7 01:31 AM | Likes Like |Link to Comment
  • A.P. Pharma: Refiling Of NDA For APF530 Could Cause Price Strength [View article]
    you should buy the makers of Aloxi, as you can throw your towel in way to late anyway. That one slide is all it takes for oncologist to go why should I put this person more than I have too.
    Oct 7 01:31 AM | Likes Like |Link to Comment
  • A.P. Pharma: Refiling Of NDA For APF530 Could Cause Price Strength [View article]
    I have been following this stock since April of 2009 when they received the first Complete Response from the FDA. The study did not show that APF530 was non-inferior it said it outlasted Aloxi which makes it a more durable method for oncologist. To me they are going to use a drug that last longer with less side affects so it does have a billion dollar expectation and long term upside you moron ,extrayield.
    Oct 4 10:27 AM | Likes Like |Link to Comment
COMMENTS STATS
4 Comments
0 Likes